Automatiserat, slutet bioreaktorsystem för expansion av adherenta celler.

Summary

Karolinska Institutet is procuring an automated closed bioreactor system for adherent cell expansion—specifically a perfusion-based bioreactor platform supporting both adherent and suspension cell cultures in a scalable, closed, automated system for its Pre-GMP facility (ANA Futura core facility). This is an open tender worth approximately 2 million SEK. The submission deadline is 11 September 2026. Suppliers of bioreactor technology with experience in closed-system solutions for cell culture are the primary target group.